Skip to content

Due to scheduled maintenance, online ordering, in regions where offered, will not be available on this site from 08:00 until noon (GMT) on Sunday 24th February. We apologise for the inconvenience.

Cart

Your Cart

×

You have 0 items in your cart.

Register Sign in Wishlist
Look Inside Bipolar II Disorder

Bipolar II Disorder
Modelling, Measuring and Managing

3rd Edition

$64.99 (G)

Gordon Parker, Edward Shorter, Chris B. Aiken, Trisha Chakrabarty, George Hadjipavlou, David J. Bond, Lakshmi N. Yatham, Stacey McCraw, Tahlia Ricciardi, Joel Paris, Adam Bayes, Emre Bora, Christos Pantelis, Gabriela Tavella, Joseph F. Goldberg, Eduard Vieta, Philip Boyce, Vijaya Manicavasagar, David Gilfillan, Margo Orum, Tessa Cleradin, Jay Amsterdam, Lorenzo Lorenzo-Luaces, Darryl Bassett p, David Castle, Kostantinos N. Fountoulakis, Sophia Frangou, Heinz Grunze, Tadafumi Kato, Gin Malhi, Philip B. Mitchell, Lawrence T. Park, Carlos A. Zarate, Jr, Robert Post, Joshua Rosenblat, Roger McIntyre, Ayal Schaffer, Michael E. Thase, Mauricio Tohen, Allan Young
View all contributors
  • Date Published: February 2019
  • availability: In stock
  • format: Paperback
  • isbn: 9781108414111

$ 64.99 (G)
Paperback

Add to cart Add to wishlist

Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focused entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. Now in its third edition, this book features new chapters on the limitations to clinical treatment trials and perinatal management nuances. In a completely new section, international experts offer their personal responses and distinctive wisdom to key management issues and allow the reader to observe a variety of opinions.

    • Covers both drug and non-drug based management strategies
    • Clinically-weighted for clinicians but also informative for patients and their families
    • Features a diverse and opinionated debate from subject experts as to the management and treatment of bipolar II
    Read more

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Edition: 3rd Edition
    • Date Published: February 2019
    • format: Paperback
    • isbn: 9781108414111
    • length: 318 pages
    • dimensions: 234 x 156 x 16 mm
    • weight: 0.56kg
    • availability: In stock
  • Table of Contents

    Part I. Domain Chapters:
    1. Mapping the terrain of bipolar II disorder Gordon Parker
    2. Bipolar disorder in historical perspective Edward Shorter
    3. The bipolar spectrum Chris B. Aiken
    4. Defining and measuring bipolar II disorder as a categorical condition Gordon Parker
    5. Bipolar II disorder in context: a review of its epidemiology, disability and economic burden Trisha Chakrabarty, George Hadjipavlou, David J. Bond and Lakshmi N. Yatham
    6. Comorbid conditions associated with bipolar II disorder Gordon Parker and Stacey McCraw
    7. Personality and temperament styles associated with bipolar II disorder Tahlia Ricciardi
    8. Differentiating bipolar II disorder from personality-based dysregulation disorders Joel Paris and Adam Bayes
    9. The neurobiology of bipolar II disorder Emre Bora and Christos Pantelis
    10. Methodological nuances in undertaking and interpreting efficacy studies of medications for bipolar II disorder Gabriela Tavella and Gordon Parker
    11. The role of antidepressants in managing bipolar II disorder Joseph F. Goldberg
    12. Mood stabilizers in the treatment of bipolar II disorder David J. Bond, George Hadjipavlou and Lakshmi N. Yatham
    13. The use of antipsychotic drugs in bipolar II disorder Eduard Vieta
    14. Perinatal nuances in managing bipolar II disorder Gabriela Tavella and Philip Boyce
    15. Psychological interventions for managing bipolar II disorder Vijaya Manicavasagar and David Gilfillan
    16. The role of wellbeing plans in managing bipolar II disorder Margo Orum
    17. The trajectory of illness experienced by those with a bipolar II disorder Tessa Cleradin
    Part II. Management Commentaries:
    18. Introduction to management commentaries Gordon Parker
    19. Management commentary Jay Amsterdam and Lorenzo Lorenzo-Luaces
    20. Management commentary Darryl Bassett
    21. Management commentary David Castle
    22. Management commentary Kostantinos N. Fountoulakis
    23. Management commentary Sophia Frangou
    24. Management commentary Heinz Grunze
    25. Management commentary Tadafumi Kato
    26. Management commentary Gin Malhi
    27. Management commentary Philip B. Mitchell
    28. Management commentary Lawrence T. Park and Carlos A. Zarate, Jr
    29. Management commentary Robert Post
    30. Management commentary Joshua Rosenblat and Roger McIntyre
    31. Management commentary Ayal Schaffer
    32. Management commentary Michael E. Thase
    33. Management commentary Mauricio Tohen
    34. Management commentary Eduard Vieta
    35. Management commentary Lakshmi Yatham
    36. Management commentary Allan Young
    Part III. Conclusion:
    37. Rounding up Gordon Parker.

  • Editor

    Gordon Parker, University of New South Wales, Sydney
    Gordon Parker is currently Scientia Professor of Psychiatry, University of New South Wales, Sydney, and was Executive Director of the Black Dog Institute from 2002 to 2011. He was, for nearly two decades, Head of the School of Psychiatry at the University of New South Wales and Director of the Division of Psychiatry at the Prince of Wales and Prince Henry Hospitals, and was part-time Research Director of the Institute of Mental Health in Singapore.

    Contributors

    Gordon Parker, Edward Shorter, Chris B. Aiken, Trisha Chakrabarty, George Hadjipavlou, David J. Bond, Lakshmi N. Yatham, Stacey McCraw, Tahlia Ricciardi, Joel Paris, Adam Bayes, Emre Bora, Christos Pantelis, Gabriela Tavella, Joseph F. Goldberg, Eduard Vieta, Philip Boyce, Vijaya Manicavasagar, David Gilfillan, Margo Orum, Tessa Cleradin, Jay Amsterdam, Lorenzo Lorenzo-Luaces, Darryl Bassett p, David Castle, Kostantinos N. Fountoulakis, Sophia Frangou, Heinz Grunze, Tadafumi Kato, Gin Malhi, Philip B. Mitchell, Lawrence T. Park, Carlos A. Zarate, Jr, Robert Post, Joshua Rosenblat, Roger McIntyre, Ayal Schaffer, Michael E. Thase, Mauricio Tohen, Allan Young

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×